New device could improve cancer detection

May 11, 2016, University of British Columbia
Hongshen Ma. Credit: UBC

A new UBC-developed method to isolate cancer cells that have escaped from a tumour could soon pave the way for improved diagnosis and treatment.

The simple process involves a special device that squeezes cells in a blood sample through tiny funnels, which drive the and into separate streams based on differences in their size and softness.

"Circulating tumour cells—cells from a tumour that have escaped into the bloodstream with the potential to spread into other tissues—are extremely useful for assessing a patient's disease in order to select the most appropriate treatment," said UBC mechanical engineering professor Hongshen Ma, the lead researcher. "These cells are particularly important for prostate cancer, where the site of metastasis is typically in the bone, where biopsies are difficult or impossible."

Ma's research focus is microfluidics, the flow of liquids through channels smaller than a human hair. The microfluidic device designed by his team captures cells based on their distinct internal structure—a mechanical analysis instead of the blood chemistry analysis used in conventional medical diagnostic techniques.

The device was first tested using blood samples spiked with cancer cells. It was then used to analyze samples from 20 patients with metastatic castration-resistant prostate cancer, an advanced form of cancer, and from four healthy individuals.

"In the first experiment, the device was able to capture more than 90 per cent of the cells," noted co-author Dr. Kim N. Chi, director of clinical research at the B.C. Cancer Agency and a professor of medicine at UBC. "Importantly, in patient samples the captured about 25 times the number of cancer cells and produced fewer false positives compared to the conventional CellSearch system, which also analyzes ."

The team is currently working on genome sequencing of individual circulating from patients at the Vancouver Prostate Centre. This would allow researchers to determine the mutations responsible for metastasis so that doctors can select the most appropriate treatment.

Explore further: Proportion of cancer stem cells can increase over the course of cancer treatment

More information: Emily S. Park et al, Continuous Flow Deformability-Based Separation of Circulating Tumor Cells Using Microfluidic Ratchets, Small (2016). DOI: 10.1002/smll.201503639

Related Stories

Life-preserver microbubbles float tumor cells for analysis

April 18, 2016

A University of Colorado Cancer Center study presented at the American Association for Cancer Research Annual Meeting 2016 demonstrates the use of gas microbubbles to selectively attach to and float circulating tumor cells ...

Recommended for you

A protein that self-replicates

February 22, 2018

ETH scientists have been able to prove that a protein structure widespread in nature – the amyloid – is theoretically capable of multiplying itself. This makes it a potential predecessor to molecules that are regarded ...

Newly designed molecule binds nitrogen

February 22, 2018

Wheat, millet and maize all need nitrogen to grow. Fertilisers therefore contain large amounts of nitrogenous compounds, which are usually synthesised by converting nitrogen to ammonia in the industrial Haber-Bosch process, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.